We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AUTHORIZED GENERICS MAY HAVE DAY IN COURT AFTER MYLAN SUES WATSON, P&G
AUTHORIZED GENERICS MAY HAVE DAY IN COURT AFTER MYLAN SUES WATSON, P&G
April 6, 2004
In the latest move against authorized generics, Mylan Laboratories has filed a lawsuit against rival Watson Pharmaceuticals and brand firm Procter & Gamble (P&G) over a deal that lets Watson market an authorized version of a P&G drug during Mylan’s 180-day marketing exclusivity period for the product.